The Pfizer/BioNTech bivalent COVID-19 vaccine (both Original and Omicron BA.4/BA.5) is already FDA-authorized under an EUA for use in individuals 12 years old and above as a single booster dose ...
Pfizer and BioNTech's Covid-19 vaccine for kids should be the topic of discussion when the FDA's vaccine advisory committee meets Tuesday. The companies said that the vaccine was effective at ...
The federal Centers for Disease Control and Prevention has added the Covid-19 vaccine ... including the bivalent booster, have emergency-use authorization for children 6 months of age and older, but ...
(The Hill) — The Food and Drug Administration (FDA) on Tuesday announced it was simplifying its recommended COVID-19 vaccine schedule, stating a single dose of the bivalent vaccine specific to ...
Pfizer submitted initial data from its COVID vaccine trial on kids between the ages of 5 and 11 to the FDA Tuesday, setting up the possibility of wide-spread vaccinations by Halloween. Pfizer ...
and the U.S. Food and Drug Administration (FDA) about a possible “safety signal” for the Pfizer-BioNTech Covid-19 bivalent booster vaccine. Not surprisingly the chatter has been a bit like the ...
The COVID vaccine may ... given with a high-dose flu shot, primarily in seniors over 85, according to new FDA analyses. The ...
The FDA announcement did mention studies that compared the use of bivalent boosters and ... she receives a Moderna Omicron Covid-19 booster ... [+] vaccine on February 17 in a clinical study ...
What’s behind the messy rollout of this fall’s new COVID ... FDA panel’s recommendation is endorsed by the CDC, only a single composition of vaccine – in this case, the updated bivalent ...
Along with allowing a second shot for some adults, the CDC is also working to streamline its COVID ... of the bivalent vaccine or whichever vaccine becomes available in the future. "FDA has ...
Last fall, U.S. health officials authorized new COVID-19 booster shots designed ... on whether a second bivalent booster dose is needed right now. However, the FDA recently proposed switching ...
The FDA's proposal follows the European regulator's backing last month for the use of bivalent COVID shots for primary vaccination.